0000899243-22-037426.txt : 20221202
0000899243-22-037426.hdr.sgml : 20221202
20221202162018
ACCESSION NUMBER: 0000899243-22-037426
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221201
FILED AS OF DATE: 20221202
DATE AS OF CHANGE: 20221202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirpekar Sahil
CENTRAL INDEX KEY: 0001951712
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40493
FILM NUMBER: 221442210
MAIL ADDRESS:
STREET 1: C/O ATAI LIFE SCIENCES N.V.
STREET 2: WALLSTRASSE 16
CITY: BERLIN
STATE: 2M
ZIP: 10179
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATAI Life Sciences N.V.
CENTRAL INDEX KEY: 0001840904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: WALLSTRASSE 16
CITY: BERLIN
STATE: 2M
ZIP: 10179
BUSINESS PHONE: (617)-699-5876
MAIL ADDRESS:
STREET 1: 524 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: ATAI Life Sciences B.V.
DATE OF NAME CHANGE: 20210115
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-01
0
0001840904
ATAI Life Sciences N.V.
ATAI
0001951712
Kirpekar Sahil
WALLSTRASSE 16
BERLIN
2M
10179
GERMANY
0
1
0
0
Chief Business Officer
Stock Option
3.34
2022-12-01
4
A
0
750000
0.00
A
2032-12-01
Common Shares
750000
750000
D
The stock option shall vest as to 25% of the underlying shares on November 29, 2023, and in 36 substantially equal monthly installments thereafter.
/s/ Ryan Barrett, Attorney-in-fact
2022-12-02